Marco Boccitto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marco Boccitto has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Sandra L. Wolin
RNA Biology Laboratory, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA
6 shared publications Sandra Wolin
RNA Biology Laboratory, National Cancer Institute, National Institutes of Health, USA
5 shared publicationsRobert G. Kalb
Neuroscience Graduate Group, University of Pennsylvania, Philadelphia, PA 19104; and
3 shared publications- Robert Gordon Kalb
Department of Neurology, Feinberg School of Medicine, Northwestern University
3 shared publications - Andrew L. Goodman
Department of Microbial Pathogenesis and Microbial Sciences Institute, Yale University School of Medicine
2 shared publications Jelena Mojsilovic-Petrovic
Division of Neurology, Department of Pediatrics, Children’s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104
2 shared publications
Latest Publications
- 10 November 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (45) , eadf7997
CLIP-Seq analysis enables the design of protective ribosomal RNA bait oligonucleotides against C9ORF72 ALS/FTD poly-GR pathophysiology
Amyotrophic lateral sclerosis and frontotemporal dementia patients with a hexanucleotide repeat expansion in C9ORF72 (C9-HRE) accumulate poly-GR and poly-PR aggregates. The pathogenicity of these arginine-rich dipeptide repeats (R-DPRs) is thought to be driven by their propensity to bind low-complexity domains of multivalent proteins. However, the ability of R-DPRs to bind native RNA and the significance of this interaction remain unclear. Here, we used computational and experimental approaches to characterize the physicochemical properties of R-DPRs and their interaction with RNA. We find that poly-GR predominantly binds ribosomal RNA (rRNA) in cells and exhibits an interaction that is predicted to be energetically stronger than that for associated ribosomal proteins. Critically, modified rRNA “bait” oligonucleotides restore poly-GR–associated ribosomal deficits and ameliorate poly-GR toxicity in patient neurons and Drosophila models. Our work strengthens the hypothesis that ribosomal function is impaired by R-DPRs, highlights a role for direct rRNA binding in mediating ribosomal dysfunction, and presents a strategy for protecting against C9-HRE pathophysiological mechanisms.
- 10 November 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (45) , eadf7997
CLIP-Seq analysis enables the design of protective ribosomal RNA bait oligonucleotides against C9ORF72 ALS/FTD poly-GR pathophysiology
Amyotrophic lateral sclerosis and frontotemporal dementia patients with a hexanucleotide repeat expansion in C9ORF72 (C9-HRE) accumulate poly-GR and poly-PR aggregates. The pathogenicity of these arginine-rich dipeptide repeats (R-DPRs) is thought to be driven by their propensity to bind low-complexity domains of multivalent proteins. However, the ability of R-DPRs to bind native RNA and the significance of this interaction remain unclear. Here, we used computational and experimental approaches to characterize the physicochemical properties of R-DPRs and their interaction with RNA. We find that poly-GR predominantly binds ribosomal RNA (rRNA) in cells and exhibits an interaction that is predicted to be energetically stronger than that for associated ribosomal proteins. Critically, modified rRNA “bait” oligonucleotides restore poly-GR–associated ribosomal deficits and ameliorate poly-GR toxicity in patient neurons and Drosophila models. Our work strengthens the hypothesis that ribosomal function is impaired by R-DPRs, highlights a role for direct rRNA binding in mediating ribosomal dysfunction, and presents a strategy for protecting against C9-HRE pathophysiological mechanisms.
- 24 June 2019
- Published by H1 Connect
Faculty Opinions recommendation of Structure and degradation of circular rnas regulate PKR activation in innate immunity.
Circular RNAs (circRNAs) formed by pre-mRNA backsplicing are widely expressed in eukaryotes. Backsplicing occurs when a downstream splice donor site is ligated to an upstream splice acceptor, allowing one or more mRNA exons to be joined together in a circular fashion (see {1,2} for review of circRNAs). While the frequency of backsplicing events is usually low compared to canonical splicing (<1%) {3}, circRNAs are longer lived than their linear counterparts because they are not substrates for exoribonucleases. How circRNAs are eventually degraded is poorly understood. The functions of these RNAs are largely unknown. This recent work by the Chen lab provides new insights into circRNA metabolism and function. They show that the endonuclease RNase L is important for circRNA degradation when cells are treated with poly(I:C) or undergo virus infection. RNase L is activated during viral infection and degrades host and viral RNAs to limit viral replication. Activation of RNase L leads to a global reduction in circRNA abundance with only a modest effect on linear RNAs. The authors also find that RNA structure may be responsible for some unique functions of circRNAs. A modified SHAPE-MaP approach compared circRNA structures to the structure of the corresponding sequence in the context of linear mRNA. This revealed that short imperfect (16-26bp) dsRNA regions are more frequent in circRNAs. The authors find that at least some structured circRNAs bind to and inhibit activation of PKR, an interferon-induced protein kinase that is normally activated by binding long dsRNAs. Increased innate immune signaling has been implicated in the pathogenesis of autoimmunity, and the authors find that circRNA expression is low in peripheral blood mononuclear cells (PBMCs) from patients with systemic lupus erythematosus (SLE) and that PKR is activated in these cells. Remarkably, overexpression of a circRNA in the patient PBMCs reduced both PKR activation and the expression of interferon-stimulated genes. Overall, this study Identifies a mechanism for circRNA degradation and a role for circRNAs in preventing PKR activation. A particularly exciting possibility is that circRNAs could potentially be used as therapeutics to reduce interferon production in SLE patients.
- 24 June 2019
- Published by H1 Connect
Faculty Opinions recommendation of Structure and degradation of circular rnas regulate PKR activation in innate immunity.
Circular RNAs (circRNAs) formed by pre-mRNA backsplicing are widely expressed in eukaryotes. Backsplicing occurs when a downstream splice donor site is ligated to an upstream splice acceptor, allowing one or more mRNA exons to be joined together in a circular fashion (see {1,2} for review of circRNAs). While the frequency of backsplicing events is usually low compared to canonical splicing (<1%) {3}, circRNAs are longer lived than their linear counterparts because they are not substrates for exoribonucleases. How circRNAs are eventually degraded is poorly understood. The functions of these RNAs are largely unknown. This recent work by the Chen lab provides new insights into circRNA metabolism and function. They show that the endonuclease RNase L is important for circRNA degradation when cells are treated with poly(I:C) or undergo virus infection. RNase L is activated during viral infection and degrades host and viral RNAs to limit viral replication. Activation of RNase L leads to a global reduction in circRNA abundance with only a modest effect on linear RNAs. The authors also find that RNA structure may be responsible for some unique functions of circRNAs. A modified SHAPE-MaP approach compared circRNA structures to the structure of the corresponding sequence in the context of linear mRNA. This revealed that short imperfect (16-26bp) dsRNA regions are more frequent in circRNAs. The authors find that at least some structured circRNAs bind to and inhibit activation of PKR, an interferon-induced protein kinase that is normally activated by binding long dsRNAs. Increased innate immune signaling has been implicated in the pathogenesis of autoimmunity, and the authors find that circRNA expression is low in peripheral blood mononuclear cells (PBMCs) from patients with systemic lupus erythematosus (SLE) and that PKR is activated in these cells. Remarkably, overexpression of a circRNA in the patient PBMCs reduced both PKR activation and the expression of interferon-stimulated genes. Overall, this study Identifies a mechanism for circRNA degradation and a role for circRNAs in preventing PKR activation. A particularly exciting possibility is that circRNAs could potentially be used as therapeutics to reduce interferon production in SLE patients.
- 4 March 2019
- Published by Taylor & Francis in Critical Reviews in Biochemistry and Molecular Biology
- Vol. 54 (2) , 133-152
Ro60 and Y RNAs: structure, functions, and roles in autoimmunity
Ro60, also known as SS-A or TROVE2, is an evolutionarily conserved RNA-binding protein that is found in most animal cells, approximately 5% of sequenced prokaryotic genomes and some archaea. Ro60 is present in cells as both a free protein and as a component of a ribonucleoprotein complex, where its best-known partners are members of a class of noncoding RNAs called Y RNAs. Structural and biochemical analyses have revealed that Ro60 is a ring-shaped protein that binds Y RNAs on its outer surface. In addition to Y RNAs, Ro60 binds misfolded and aberrant noncoding RNAs in some animal cell nuclei. Although the fate of these defective Ro60-bound noncoding RNAs in animal cells is not well-defined, a bacterial Ro60 ortholog functions with 3′ to 5′ exoribonucleases to assist structured RNA degradation. Studies of Y RNAs have revealed that these RNAs regulate the subcellular localization of Ro60, tether Ro60 to effector proteins and regulate the access of other RNAs to its central cavity. As both mammalian cells and bacteria lacking Ro60 are sensitized to ultraviolet irradiation, Ro60 function may be important during exposure to some environmental stressors. Here we summarize the current knowledge regarding the functions of Ro60 and Y RNAs in animal cells and bacteria. Because the Ro60 RNP is a clinically important target of autoantibodies in patients with rheumatic diseases such as Sjogren’s syndrome, systemic lupus erythematosus, and neonatal lupus, we also discuss potential roles for Ro60 RNPs in the initiation and pathogenesis of systemic autoimmune rheumatic disease.
- 4 March 2019
- Published by Taylor & Francis in Critical Reviews in Biochemistry and Molecular Biology
- Vol. 54 (2) , 133-152
Ro60 and Y RNAs: structure, functions, and roles in autoimmunity
Ro60, also known as SS-A or TROVE2, is an evolutionarily conserved RNA-binding protein that is found in most animal cells, approximately 5% of sequenced prokaryotic genomes and some archaea. Ro60 is present in cells as both a free protein and as a component of a ribonucleoprotein complex, where its best-known partners are members of a class of noncoding RNAs called Y RNAs. Structural and biochemical analyses have revealed that Ro60 is a ring-shaped protein that binds Y RNAs on its outer surface. In addition to Y RNAs, Ro60 binds misfolded and aberrant noncoding RNAs in some animal cell nuclei. Although the fate of these defective Ro60-bound noncoding RNAs in animal cells is not well-defined, a bacterial Ro60 ortholog functions with 3′ to 5′ exoribonucleases to assist structured RNA degradation. Studies of Y RNAs have revealed that these RNAs regulate the subcellular localization of Ro60, tether Ro60 to effector proteins and regulate the access of other RNAs to its central cavity. As both mammalian cells and bacteria lacking Ro60 are sensitized to ultraviolet irradiation, Ro60 function may be important during exposure to some environmental stressors. Here we summarize the current knowledge regarding the functions of Ro60 and Y RNAs in animal cells and bacteria. Because the Ro60 RNP is a clinically important target of autoantibodies in patients with rheumatic diseases such as Sjogren’s syndrome, systemic lupus erythematosus, and neonatal lupus, we also discuss potential roles for Ro60 RNPs in the initiation and pathogenesis of systemic autoimmune rheumatic disease.
- 15 August 2018
- Published by H1 Connect
Faculty Opinions recommendation of Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation.
In addition to promoting nuclear export and enhancing translation, a major function of poly-adenylation is to protect eukaryotic mRNAs from degradation. Cytoplasmic deadenylation of mRNAs is carried out predominantly by the CCR4-NOT complex and is an important regulatory step in mRNA degradation. Previous work by the Kim lab revealed an additional layer of complexity in this process. Once mRNA poly(A) tails become too short to be bound by the poly(A) binding protein PABP, they become substrates for TUT4/TUT7, which add non-templated uridines to the 3’ end of the poly(A) tail {1}. This non-templated uridylation promotes degradation of mRNAs harboring this modification. In the current work, Lim et al. identify a new way in which non-templated nucleotides influence mRNA half-lives. They find that the terminal nucleotidyltransferases TENT4A (also known as TUT5, PAPD7 and hTRF4-1) and TENT4B (also called TUT3, PAPD5 and hTRF4-2) generate polynucleotide tails consisting predominantly of As but also sporadically incorporating G, C and U with a frequency of 15.5%, 5.7% and 5.2%, respectively. These non-A nucleotides hinder mRNA deadenylation by the CCR4-NOT complex. The CCR4-NOT complex stalls when it encounters a non-A nucleotide, thus enriching for mRNAs containing a terminal or penultimate non-A residue. Using TAIL-seq, a method that recovers 3’ end sequences on a transcriptome-wide level {2}, Lim et al. showed that many mRNAs in two human cell lines, HeLa and human foreskin fibroblasts, carry this terminal/penultimate non-A signature. Depletion of TENT4A and TENT4B led to a decrease in the abundance of those transcripts that showed the most mixed tailing. Taken together, these findings reveal that mixed tailing is yet another mechanism by which mRNA stability can be modulated.
- 15 August 2018
- Published by H1 Connect
Faculty Opinions recommendation of Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation.
In addition to promoting nuclear export and enhancing translation, a major function of poly-adenylation is to protect eukaryotic mRNAs from degradation. Cytoplasmic deadenylation of mRNAs is carried out predominantly by the CCR4-NOT complex and is an important regulatory step in mRNA degradation. Previous work by the Kim lab revealed an additional layer of complexity in this process. Once mRNA poly(A) tails become too short to be bound by the poly(A) binding protein PABP, they become substrates for TUT4/TUT7, which add non-templated uridines to the 3’ end of the poly(A) tail {1}. This non-templated uridylation promotes degradation of mRNAs harboring this modification. In the current work, Lim et al. identify a new way in which non-templated nucleotides influence mRNA half-lives. They find that the terminal nucleotidyltransferases TENT4A (also known as TUT5, PAPD7 and hTRF4-1) and TENT4B (also called TUT3, PAPD5 and hTRF4-2) generate polynucleotide tails consisting predominantly of As but also sporadically incorporating G, C and U with a frequency of 15.5%, 5.7% and 5.2%, respectively. These non-A nucleotides hinder mRNA deadenylation by the CCR4-NOT complex. The CCR4-NOT complex stalls when it encounters a non-A nucleotide, thus enriching for mRNAs containing a terminal or penultimate non-A residue. Using TAIL-seq, a method that recovers 3’ end sequences on a transcriptome-wide level {2}, Lim et al. showed that many mRNAs in two human cell lines, HeLa and human foreskin fibroblasts, carry this terminal/penultimate non-A signature. Depletion of TENT4A and TENT4B led to a decrease in the abundance of those transcripts that showed the most mixed tailing. Taken together, these findings reveal that mixed tailing is yet another mechanism by which mRNA stability can be modulated.
- 26 April 2018
- Published by H1 Connect
- Vol. 69 (3)
Faculty Opinions recommendation of Senataxin Mutation Reveals How R-Loops Promote Transcription by Blocking DNA Methylation at Gene Promoters.
Grunseich et al. investigate the mechanism by which the L389S mutation in the RNA/DNA helicase senataxin (SETX) results in the motor neuron disease amyotrophic lateral sclerosis 4 (ALS4). Their findings suggest that decreased R-loop formation, due to an apparent gain of function mutation in SETX, reduces expression of BAMBI, an inhibitor of TGF-b signaling. The resulting aberrant activation of the TGF-β pathway may lead to...
- 26 April 2018
- Published by H1 Connect
- Vol. 69 (3)
Faculty Opinions recommendation of Senataxin Mutation Reveals How R-Loops Promote Transcription by Blocking DNA Methylation at Gene Promoters.
Grunseich et al. investigate the mechanism by which the L389S mutation in the RNA/DNA helicase senataxin (SETX) results in the motor neuron disease amyotrophic lateral sclerosis 4 (ALS4). Their findings suggest that decreased R-loop formation, due to an apparent gain of function mutation in SETX, reduces expression of BAMBI, an inhibitor of TGF-b signaling. The resulting aberrant activation of the TGF-β pathway may lead to...
- Top Cited Papers
- 28 March 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 10 (434)
Commensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus
Commensal bacterial orthologs of the human autoantigen Ro60 may trigger cross-reactive T and B cells that initiate and sustain chronic autoimmunity in lupus.
- 28 March 2018
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 10 (434)
Top Cited PapersCommensal orthologs of the human autoantigen Ro60 as triggers of autoimmunity in lupus
Commensal bacterial orthologs of the human autoantigen Ro60 may trigger cross-reactive T and B cells that initiate and sustain chronic autoimmunity in lupus.
- 4 December 2017
- Published by H1 Connect
Faculty Opinions recommendation of Widespread Influence of 3'-End Structures on Mammalian mRNA Processing and Stability.
For many RNAs, structure and function are innately linked. Although this relationship is well established for many noncoding RNAs (ncRNAs), whether structure plays an important role in mRNA biogenesis or function is less clear. For mRNAs, the ability to encode structure is limited by the need to also encode a functional open reading frame. However, in silico analyses have found that even the 5’ and 3’ untranslated regions of mRNAs are no more likely to fold than random sequences with the same nucleotide composition {1}. In this work, Wu and Bartel demonstrate that 3’ end structures play a crucial role in polyadenylation and stability of human mRNAs. Polyadenylation is a critical step in mRNA maturation. This process occurs via cleavage downstream of the poly(A) signal (PAS) AAUAAA, followed by addition of a poly(A) tail by poly(A) polymerase. Previous work had determined that 10-30 nt was the optimal distance between the PAS and the site of cleavage and polyadenylation {2}. Wu and Bartel analyzed genome wide PAS-poly(A) site distance as well as a library of over 400,000 artificial PAS-poly(A) site sequences. They found that mRNAs with longer PAS-poly(A) site distances utilize folding within the PAS-poly(A) region to reduce the PAS-poly(A) site distance. Using in vivo structure probing, they confirmed the existence of these structured regions in thousands of human mRNAs. They also found that the PAS-poly(A) site distance influences mRNA stability, and that this effect is similarly modified by 3’ end structures. This work beautifully demonstrates that many human mRNAs rely on folding to achieve proper 3’ end processing and enhance mRNA stability. Interestingly, although mRNA folding is functionally important, it differs from ncRNA folding in significant ways. Unlike ncRNAs which fold into very stable and structurally unique elements, folds in mRNA PAS-poly(A) site regions are not constrained to a unique structure, and may simply act to modify the effective length between the PAS and the poly(A) site. The broader implication of this work is that loosely constrained, yet functionally significant, folds likely exist throughout mRNAs.
- 4 December 2017
- Published by H1 Connect
Faculty Opinions recommendation of Widespread Influence of 3'-End Structures on Mammalian mRNA Processing and Stability.
For many RNAs, structure and function are innately linked. Although this relationship is well established for many noncoding RNAs (ncRNAs), whether structure plays an important role in mRNA biogenesis or function is less clear. For mRNAs, the ability to encode structure is limited by the need to also encode a functional open reading frame. However, in silico analyses have found that even the 5’ and 3’ untranslated regions of mRNAs are no more likely to fold than random sequences with the same nucleotide composition {1}. In this work, Wu and Bartel demonstrate that 3’ end structures play a crucial role in polyadenylation and stability of human mRNAs. Polyadenylation is a critical step in mRNA maturation. This process occurs via cleavage downstream of the poly(A) signal (PAS) AAUAAA, followed by addition of a poly(A) tail by poly(A) polymerase. Previous work had determined that 10-30 nt was the optimal distance between the PAS and the site of cleavage and polyadenylation {2}. Wu and Bartel analyzed genome wide PAS-poly(A) site distance as well as a library of over 400,000 artificial PAS-poly(A) site sequences. They found that mRNAs with longer PAS-poly(A) site distances utilize folding within the PAS-poly(A) region to reduce the PAS-poly(A) site distance. Using in vivo structure probing, they confirmed the existence of these structured regions in thousands of human mRNAs. They also found that the PAS-poly(A) site distance influences mRNA stability, and that this effect is similarly modified by 3’ end structures. This work beautifully demonstrates that many human mRNAs rely on folding to achieve proper 3’ end processing and enhance mRNA stability. Interestingly, although mRNA folding is functionally important, it differs from ncRNA folding in significant ways. Unlike ncRNAs which fold into very stable and structurally unique elements, folds in mRNA PAS-poly(A) site regions are not constrained to a unique structure, and may simply act to modify the effective length between the PAS and the poly(A) site. The broader implication of this work is that loosely constrained, yet functionally significant, folds likely exist throughout mRNAs.
- Open Access
- 26 October 2017
- Published by Wiley in Arthritis & Rheumatology
- Vol. 70 (2) , 298-307
Accumulation of Antigen‐Driven Lymphoproliferations in Complement Receptor 2/CD21−/low B Cells From Patients With Sjögren's Syndrome
Objective: Patients with Sjögren's syndrome (SS) are prone to develop malignant lymphomas, and a correlation has been established between the lymphoproliferations occurring in these disorders and the presence in patients’ blood of an unusual B cell population that down‐regulates complement receptor 2/CD21. This study was undertaken to identify the B cell compartment from which these lymphoproliferations emerge and determine the mechanisms that promote clonal B cell expansion in patients with SS.Methods: The reactivity of antibodies expressed by CD19+CD10−CD27−IgM+CD21−/low cells isolated from the blood of patients with SS was tested using a polymerase chain reaction–based approach that allows us to clone and express, in vitro, recombinant antibodies produced by single B cells.Results: Clonal expansions were identified in CD21−/low B cells isolated from the peripheral blood of 3 patients with SS. These lymphoproliferations expressed B cell receptors (BCRs) that displayed somatic hypermutation lineage trees characteristic of a strong selection by antigens; one of these antigens was identified as a ribosomal self antigen. When the mutated BCR sequences expressed by the expanded CD21−/low B cell clones from patients with SS were reverted in vitro to their germline counterparts, one clone remained autoreactive.Conclusion: Clonal lymphoproliferations in patients with SS preferentially accumulate in the autoreactive CD21−/low B cell compartment often expanded in these subjects, and recognition of self antigens may drive the clonal B cell expansion while further refining BCR self‐reactivity.
- 26 October 2017
- Published by Wiley in Arthritis & Rheumatology
- Vol. 70 (2) , 298-307
Open AccessAccumulation of Antigen‐Driven Lymphoproliferations in Complement Receptor 2/CD21−/low B Cells From Patients With Sjögren's Syndrome
Objective: Patients with Sjögren's syndrome (SS) are prone to develop malignant lymphomas, and a correlation has been established between the lymphoproliferations occurring in these disorders and the presence in patients’ blood of an unusual B cell population that down‐regulates complement receptor 2/CD21. This study was undertaken to identify the B cell compartment from which these lymphoproliferations emerge and determine the mechanisms that promote clonal B cell expansion in patients with SS.Methods: The reactivity of antibodies expressed by CD19+CD10−CD27−IgM+CD21−/low cells isolated from the blood of patients with SS was tested using a polymerase chain reaction–based approach that allows us to clone and express, in vitro, recombinant antibodies produced by single B cells.Results: Clonal expansions were identified in CD21−/low B cells isolated from the peripheral blood of 3 patients with SS. These lymphoproliferations expressed B cell receptors (BCRs) that displayed somatic hypermutation lineage trees characteristic of a strong selection by antigens; one of these antigens was identified as a ribosomal self antigen. When the mutated BCR sequences expressed by the expanded CD21−/low B cell clones from patients with SS were reverted in vitro to their germline counterparts, one clone remained autoreactive.Conclusion: Clonal lymphoproliferations in patients with SS preferentially accumulate in the autoreactive CD21−/low B cell compartment often expanded in these subjects, and recognition of self antigens may drive the clonal B cell expansion while further refining BCR self‐reactivity.
- 1 September 2017
- Published by H1 Connect
- Vol. 548 (7667)
Faculty Opinions recommendation of mRNA 3' uridylation and poly(A) tail length sculpt the mammalian maternal transcriptome.
Mammalian cells use multiple mechanisms to maintain their RNAs at homeostatic levels. The addition of uridines to mRNA 3’ ends has emerged as a critical step in targeting mRNAs for degradation. Terminal uridylyl transferases 4 and 7 (TUT4, TUT7) are the major uridylases in the mammalian cytoplasm. Uridylation of mRNA 3’ ends enhances recruitment of the LSM1-7 complex, which leads to 5’ decapping and subsequent...
- 1 September 2017
- Published by H1 Connect
- Vol. 548 (7667)
Faculty Opinions recommendation of mRNA 3' uridylation and poly(A) tail length sculpt the mammalian maternal transcriptome.
Mammalian cells use multiple mechanisms to maintain their RNAs at homeostatic levels. The addition of uridines to mRNA 3’ ends has emerged as a critical step in targeting mRNAs for degradation. Terminal uridylyl transferases 4 and 7 (TUT4, TUT7) are the major uridylases in the mammalian cytoplasm. Uridylation of mRNA 3’ ends enhances recruitment of the LSM1-7 complex, which leads to 5’ decapping and subsequent...
- Open Access
- 7 August 2017
- Published by MDPI AG in Marine Drugs
- Vol. 15 (8) , 246
The Neuroprotective Marine Compound Psammaplysene A Binds the RNA-Binding Protein HNRNPK
In previous work, we characterized the strong neuroprotective properties of the marine compound Psammaplysene A (PA) in in vitro and in vivo models of neurodegeneration. Based on its strong neuroprotective activity, the current work attempts to identify the physical target of PA to gain mechanistic insight into its molecular action. Two distinct methods, used in parallel, to purify protein-binding partners of PA led to the identification of HNRNPK as a direct target of PA. Based on surface plasmon resonance, we find that the binding of PA to HNRNPK is RNA-dependent. These findings suggest a role for HNRNPK-dependent processes in neurodegeneration/neuroprotection, and warrant further study of HNRNPK in this context.
- 7 August 2017
- Published by MDPI AG in Marine Drugs
- Vol. 15 (8) , 246
Open AccessThe Neuroprotective Marine Compound Psammaplysene A Binds the RNA-Binding Protein HNRNPK
In previous work, we characterized the strong neuroprotective properties of the marine compound Psammaplysene A (PA) in in vitro and in vivo models of neurodegeneration. Based on its strong neuroprotective activity, the current work attempts to identify the physical target of PA to gain mechanistic insight into its molecular action. Two distinct methods, used in parallel, to purify protein-binding partners of PA led to the identification of HNRNPK as a direct target of PA. Based on surface plasmon resonance, we find that the binding of PA to HNRNPK is RNA-dependent. These findings suggest a role for HNRNPK-dependent processes in neurodegeneration/neuroprotection, and warrant further study of HNRNPK in this context.